NBY News and Press, NovaBay Pharmaceuticals Inc. From 05/09/19

Conference call begins today at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three mon...

Management to discuss new partner pharmacy program and expanded access to in-office direct channel NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, an...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, announces that it will hold a virtual Annual Meeting of Stockholders on Thursday, May 30, 2019 at 5:00 p.m. Pac...

Affirms long-term commitment to make Avenova convenient for both eye care specialists and patients NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company, announces a new pharmacy partnering program in a continued effort to ensure all patients in the...

Gainers:  AVEO Pharmaceuticals (NASDAQ: AVEO ) +35% . ADMA Biologics (NASDAQ: ADMA ) +32% . Sangamo Therapeutics (NASDAQ: SGMO ) +27% . Castor Maritime (NASDAQ: CTRM ) +24% . EDAP TMS S.A. (NASDAQ: EDAP ) +23% . Riot Blockchain (NASDAQ: RIOT ) +22% . Vaccinex (NASDAQ: VCNX ) +1...

NovaBay Pharmaceuticals (NYSEMKT: NBY )  invests $5M to support commercialization of Avenova sales in U.S. while maintaining cost effectiveness. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Reiterates long-term commitment to eye care specialists and patients Capital investment supports cost-efficient growth strategy NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the...

NovaBay Pharmaceuticals, Inc (NBY) Q4 2018 Results Earnings Conference Call March 28, 2019 04:30 PM ET Company Participants Bruce Voss - IR, LHA Justin Hall - Interim President and CEO Jason Raleigh - Interim CFO Conference Call Participants Yi Chen - H.C. Wainwright ...

NovaBay (NYSEMKT: NBY ): Q4 GAAP EPS of -$0.07 misses by $0.01 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Conference call begins today at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three and...